Merck is undervalued with strong growth, profitability, and credit strength despite CDMO challenges, offering compelling ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Merck KGaA (MKKGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Merck Foundation Together with African and Asian First Ladies Mark 'World Assisted Reproductive Technology Day' 2025 ...

Merck Foundation has pioneered a new era in fertility care across Africa and Asia by training local embryologists and ...

Merck Foundation has produced nearly 30 original songs that speak to infertility, female empowerment, and reproductive rights ...

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...

Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...

Facing an end to Keytruda's market exclusivity, the company will cut $3 billion in costs that it plans to redeploy in support ...

Merck & Co said on Tuesday it was extending its hold on Gardasil shipments to China until at least the end of 2025 due to ...

Merck’s stock is falling after a rare revenue miss, and the announcement of a $3 billion cost-cutting plan that will include ...